AzTrials
AzTrials

PhysiopathologySPIDDNCT05775562

Early Pulmonary Effects of Excursion Deep Diving With Closed-circuit Gas Recycling: SPIDD Study

A study testing Pre and post dive examinations in people with Physiopathology, run by University Hospital, Brest at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Scuba diving with closed circuit gas rebreathers is currently booming. Initially developed for professional and military diving, this type of diving has become very successful in recreational activities. The possibilities offered by this equipment are immense and reduce the constraints of exploration time and depth. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Physiopathology
What is being tested?
Pre and post dive examinations
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteFrance
Study dates
19 Sep 2023to 6 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Diver ≥ 18 years old
  • Recreational rebreather diver with a recognised qualification (Mixed Gas CCR training or equivalent) and the necessary experience for this type of diving who has scheduled a dive in the 60 metre depth zone
  • Diver using his/her own equipment, i.e. a closed circuit rebreather with back lungs meeting CE standards.
  • Having a medical certificate of no contraindication to the practice of underwater activities < 1 year issued by an authorised doctor
  • Having taken out personal insurance covering this type of activity
  • Voluntary and having given his/her express, free and informed consent
  • Affiliated to the Social Security

Who cannot join

  • Diver refusal
  • Known previous respiratory pathology
  • Use of medication that may alter pulmonary and/or vascular function as well as inflammatory and haemostasis parameters
  • Any temporary contraindication to the practice of scuba diving
  • Patient under guardianship or trusteeship
  • Immersion beyond 30 metres within 7 days or any scuba diving within the previous 48 hours.

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de BREST

    Brest, 29200

Other trials in France

About this study

Scuba diving with closed circuit gas rebreathers is currently booming. Initially developed for professional and military diving, this type of diving has become very successful in recreational activities.

The possibilities offered by this equipment are immense and reduce the constraints of exploration time and depth. More and more divers are seeking to reach depths previously considered unusual or inaccessible in recreational diving, beyond 100 meters. By pushing back these limits, the diver is exposed to new risks which should lead to a reflection on the means of prevention and treatment in case of incident.

Read more

The physiological repercussions of these deep dives are not well known. During daily deep excursions in the 90-120 meter zone, there is a significant reduction in vital capacity on leaving the dive, which persists and worsens the following day.

It seems necessary to confirm the importance of this impairment, never documented before, and to explore its mechanisms. A better knowledge of this respiratory impact could allow to improve the prevention and the preliminary evaluation of the medical aptitude of these divers.

Conditions
Physiopathology
Being tested
Pre and post dive examinations

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pre and post dive examinationsDiagnostic test

    Performing pre-dive examinations:

    • EFR by plethysmography cabin

    Realization of the examinations the day of the dive:

    • Portable Spirometry
    • Pulmonary ultrasound
    • Cardiac ultrasound
    • Measurement of circulating bubbles
    • ECG
    • Venous blood sampling (biological collection)
    • Water balance (Δweight/water intake)
    • EFR by plethysmography cabin
    • Weight measurement

    Realization of the examinations the day after the dive:

    • Venous blood sample (biological collection)
    • Portable Spirometry
    • Pulmonary ultrasound
    • Cardiac ultrasound
    • Weight measurement
Study groups in NCT05775562
Study groupRoleWhat they receive
Diving armOtherThe standard arm involves all participants in the study. Subjects will perform pre-dive and post-dive examinations to characterize the respiratory impact of deep water diving
Receives: Diagnostic Test: Pre and post dive examinations

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Variation in Vital Capacity Measurement before and after diving

    Vital capacity measurement will be performed by plethysmography and spirometry (Measurement of mobilizable and non-mobilizable lung volumes (mL))

    Measured: Day 0 (before diving)

  2. Variation in Vital Capacity Measurement before and after diving

    Vital capacity measurement will be performed by plethysmography and spirometry (Measurement of mobilizable and non-mobilizable lung volumes (mL))

    Measured: Day 0 (after diving)

  3. Variation in Vital Capacity Measurement before and after diving

    Vital capacity measurement will be performed by plethysmography and spirometry (Measurement of mobilizable and non-mobilizable lung volumes (mL))

    Measured: Day +1

Secondary outcomes (44)
  1. Variations in Spirometry data before and after diving

    Measurement of SPO2 (%), CVF (L), VEMS (L), VEMS/CVF (%), DEP (L/S) and DEMM (L/S) before and after diving by spirometry

    Measured: Day -XX before diving

  2. Variations in Spirometry data before and after diving

    Measurement of SPO2 (%), CVF (L), VEMS (L), VEMS/CVF (%), DEP (L/S) and DEMM (L/S) before and after diving by spirometry

    Measured: Day 0 (before diving)

  3. Variations in Spirometry data before and after diving

    Measurement of SPO2 (%), CVF (L), VEMS (L), VEMS/CVF (%), DEP (L/S) and DEMM (L/S) before and after diving by spirometry

    Measured: Day 0 (after diving)

  4. Variations in Spirometry data before and after diving

    Measurement of SPO2 (%), CVF (L), VEMS (L), VEMS/CVF (%), DEP (L/S) and DEMM (L/S) before and after diving by spirometry

    Measured: Day +1

  5. Variations in plethysmography data before and after diving

    Measurement of CV max (L), CVF (L), VRE (L), VRI (L), VT (L), VEMS (L), VR (L) and CPT (L) before and after diving by plethysmography

    Measured: Day -XX before Day 0

  6. Variations in plethysmography data before and after diving

    Measurement of DEP (L.S), DEM 75 (L/S), DEM 50 (L/s), DEM 25 (L/S) before and after diving by plethysmography

    Measured: Day -XX before Day 0

  7. Variations in plethysmography data before and after diving

    Measurement of CV max (L), CVF (L), VRE (L), VRI (L), VT (L), VEMS (L), VR (L) and CPT (L) before and after diving by plethysmography

    Measured: Day 0 (before diving)

  8. Variations in plethysmography data before and after diving

    Measurement of DEP (L.S), DEM 75 (L/S), DEM 50 (L/s), DEM 25 (L/S) before and after diving by plethysmography

    Measured: Day 0 (before diving)

  9. Variations in plethysmography data before and after diving

    Measurement of CV max (L), CVF (L), VRE (L), VRI (L), VT (L), VEMS (L), VR (L) and CPT (L) before and after diving by plethysmography

    Measured: Day 0 (after diving)

  10. Variations in plethysmography data before and after diving

    Measurement of DEP (L.S), DEM 75 (L/S), DEM 50 (L/s), DEM 25 (L/S) before and after diving by plethysmography

    Measured: Day 0 (after diving)

  11. Variations in plethysmography data before and after diving

    Measurement of CV max (L), CVF (L), VRE (L), VRI (L), VT (L), VEMS (L), VR (L) and CPT (L) before and after diving by plethysmography

    Measured: Day +1

  12. Variations in plethysmography data before and after diving

    Measurement of DEP (L.S), DEM 75 (L/S), DEM 50 (L/s), DEM 25 (L/S) before and after diving by plethysmography

    Measured: Day +1

  13. Variations in DLCO before and after diving

    Measurement DLCO (mmol/(min*kPa) before and after diving

    Measured: Day 0 (before diving)

  14. Variations in DLCO before and after diving

    Measurement DLCO (mmol/(min*kPa) before and after diving

    Measured: Day 0 (after diving)

  15. Variations in DLCO before and after diving

    Measurement DLCO (mmol/(min*kPa) before and after diving

    Measured: Day +1

  16. Variations in lung ultrasound (B lines) before and after diving

    A B-line count should be performed, which is defined as vertical artefacts, mobile with breathing, continuous, originating from the pleural line and erasing the other artefacts. These artefacts indicate interstitial damage, the importance of which correlates with their number and a very good correlation with the quantity of extrapulmonary water.

    Measured: Day 0 (before diving)

  17. Variations in lung ultrasound (B lines) before and after diving

    A B-line count should be performed, which is defined as vertical artefacts, mobile with breathing, continuous, originating from the pleural line and erasing the other artefacts. These artefacts indicate interstitial damage, the importance of which correlates with their number and a very good correlation with the quantity of extrapulmonary water.

    Measured: Day 0 (after diving)

  18. Variations in lung ultrasound (B lines) before and after diving

    A B-line count should be performed, which is defined as vertical artefacts, mobile with breathing, continuous, originating from the pleural line and erasing the other artefacts. These artefacts indicate interstitial damage, the importance of which correlates with their number and a very good correlation with the quantity of extrapulmonary water.

    Measured: Day +1

  19. Variations in lung ultrasound (condensations) before and after diving

    Ultrasound signs of condensation or pleural effusions should be observed before and after diving.

    Measured: Day 0 (before diving)

  20. Variations in lung ultrasound (condensations) before and after diving

    Ultrasound signs of condensation or pleural effusions should be observed before and after diving.

    Measured: Day 0 (after diving)

  21. Variations in lung ultrasound (condensations) data before and after diving

    Ultrasound signs of condensation or pleural effusions should be observed before and after diving.

    Measured: Day +1

  22. Variations in cardiac ultrasound pulmonary pressure (PAPs) before and after diving

    Pulmonary arterial pressures are assessed by studying pulmonary artery Doppler flow (Acceleration Time) and right ventricular ejection time (RVET) and calculating the Acceleration/RVET ratio.

    Measured: Day 0 (before diving)

  23. Variations in cardiac ultrasound pulmonary pressure (PAPs) before and after diving

    Pulmonary arterial pressures are assessed by studying pulmonary artery Doppler flow (Acceleration Time) and right ventricular ejection time (RVET) and calculating the Acceleration/RVET ratio.

    Measured: Day 0 (after diving)

  24. Variations in cardiac ultrasound pulmonary pressure (PAPs) before and after diving

    Pulmonary arterial pressures are assessed by studying pulmonary artery Doppler flow (Acceleration Time) and right ventricular ejection time (RVET) and calculating the Acceleration/RVET ratio.

    Measured: Day +1

  25. Variations in right ventricle function data before and after diving

    Right ventricular systolic function is assessed by measuring the tricuspid annulus plane systolic excursion (TAPSE) in TM mode and calculating the LV shortening fraction.

    Measured: Day 0 (before diving)

  26. Variations in right ventricle function data before and after diving

    Right ventricular systolic function is assessed by measuring the tricuspid annulus plane systolic excursion (TAPSE) in TM mode and calculating the LV shortening fraction.

    Measured: Day 0 (after diving)

  27. Variations in right ventricle function data before and after diving

    Right ventricular systolic function is assessed by measuring the tricuspid annulus plane systolic excursion (TAPSE) in TM mode and calculating the LV shortening fraction.

    Measured: Day +1

  28. Variations in decompression (circulating bubbles) data before and after diving

    Detection of circulating bubbles by trans-thoracic ultrasound

    Measured: Day 0 (before diving)

  29. Variations in decompression (circulating bubbles) data before and after diving

    Detection of circulating bubbles by trans-thoracic ultrasound

    Measured: Day 0 (after diving)

  30. Variations in biological markers of coagulation activation before and after diving

    Measurement from the serum library (venous blood samples) of coagulation factors (TFPI, procoagulant microparticles, Fibrin monomer, PF4, C3a, C5a and platelet count) before and after diving. The analyses remain to be specified according to the results of other ongoing investigations

    Measured: Day 0 (before diving)

  31. Variations in biological markers of coagulation activation before and after diving

    Measurement from the serum library (venous blood samples) of coagulation factors (TFPI, procoagulant microparticles, Fibrin monomer, PF4, C3a, C5a and platelet count) before and after diving. The analyses remain to be specified according to the results of other ongoing investigations

    Measured: Day 0 (after diving)

  32. Variations in biological markers of coagulation activation before and after diving

    Measurement from the serum library (venous blood samples) of coagulation factors (TFPI, procoagulant microparticles, Fibrin monomer, PF4, C3a, C5a and platelet count) before and after diving. The analyses remain to be specified according to the results of other ongoing investigations

    Measured: Day +1

  33. Variations in biomarkers of lipid peroxidation before and after diving

    Measurement from the serum library (venous blood samples) of lipoperoxidation (F2-Isoprostane) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations.

    Measured: Day 0 (before diving)

  34. Variations in biomarkers of lipid peroxidation before and after diving

    Measurement from the serum library (venous blood samples) lipoperoxidation (F2-Isoprostane) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations.

    Measured: Day 0 (after diving)

  35. Variations in biomarkers of lipid peroxidation before and after diving

    Measurement from the serum library (venous blood samples) lipoperoxidation (F2-Isoprostane) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations.

    Measured: Day +1

  36. Variations in biomarkers of oxidative stress before and after diving

    Measurement from the serum library (venous blood samples) of oxidative stress factors before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations.

    Measured: Day 0 (before diving)

  37. Variations in biomarkers of oxidative stress before and after diving

    Measurement from the serum library (venous blood samples) of oxidative stress factors before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations.

    Measured: Day 0 (after diving)

  38. Variations in biomarkers of oxidative stress before and after diving

    Measurement from the serum library (venous blood samples) of oxidative stress factors (as F2-Isoprostane, 8-isoprostane) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations.

    Measured: Day +1

  39. Variations in biological markers of inflammation before and after diving

    Measurement of inflammation factors (CRP and IL1-β) from the serum library (venous blood samples) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations.

    Measured: Day 0 (before diving)

  40. Variations in biological markers of inflammation before and after diving

    Measurement of inflammation factors (CRP and IL1-β) from the serum library (venous blood samples) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations.

    Measured: Day 0 (after diving)

  41. Variations in biological markers of inflammation before and after diving

    Measurement of inflammation factors (CRP and IL1-β) from the serum library (venous blood samples) before and after the dive. The analyses remain to be specified according to the results of other ongoing investigations.

    Measured: Day +1

  42. Variations in water balance before and after diving

    Pre- and post-dive water intakes are quantified but no intake restrictions are requested : Weight measured by electronic scale (in kg)

    Measured: Day 0 (before diving)

  43. Variations in water balance before and after diving

    Pre- and post-dive water intakes are quantified but no intake restrictions are requested : Weight measured by electronic scale (in kg)

    Measured: Day 0 (after diving)

  44. Variations in water balance before and after diving

    Pre- and post-dive water intakes are quantified but no intake restrictions are requested : Weight measured by electronic scale (in kg)

    Measured: Day +1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2023
  2. Study start19 Sep 2023
  3. Primary completion6 Sep 2024
  4. Study completion6 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05775562
Sponsor's protocol ID
29BRC21.0273
Acronym
SPIDD
Status last verified
Jun 2026
First submitted
14 Dec 2022
Last updated
17 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All collected data that underlie results in a publication

Questions about this trial

What is this clinical trial studying?

A study testing Pre and post dive examinations in people with Physiopathology, run by University Hospital, Brest at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Variation in Vital Capacity Measurement before and after diving (time frame: Day 0 (before diving)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in